<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31701321</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-0972</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>35</Volume>
            <Issue>11</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Nov</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>World journal of microbiology &amp; biotechnology</Title>
          <ISOAbbreviation>World J Microbiol Biotechnol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Metabolomic studies of Pseudomonas aeruginosa.</ArticleTitle>
        <Pagination>
          <StartPage>178</StartPage>
          <MedlinePgn>178</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">178</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11274-019-2739-1</ELocationID>
        <Abstract>
          <AbstractText>Pseudomonas aeruginosa is a common, Gram-negative environmental organism. It can be a significant pathogenic factor of severe infections in humans, especially in cystic fibrosis patients. Due to its natural resistance to antibiotics and the ability to form biofilms, infection with this pathogen can cause severe therapeutic problems. In recent years, metabolomic studies of P. aeruginosa have been performed. Therefore, in this review, we discussed recent achievements in the use of metabolomics methods in bacterial identification, differentiation, the interconnection between genome and metabolome, the influence of external factors on the bacterial metabolome and identification of new metabolites produced by P. aeruginosa. All of these studies may provide valuable information about metabolic pathways leading to an understanding of the adaptations of bacterial strains to a host environment, which can lead to new drug development and/or elaboration of new treatment and diagnostics strategies for Pseudomonas.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mielko</LastName>
            <ForeName>Karolina Anna</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Bioorganic Chemistry Group, Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-373, Wroclaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jabłoński</LastName>
            <ForeName>Sławomir Jan</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Biotransformation Department, University of Wroclaw, Plac Uniwersytecki 1, 50-137, Wroclaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Milczewska</LastName>
            <ForeName>Justyna</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Mother and Child Institute, Kasprzaka 17a, 01-211, Warszawa, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sands</LastName>
            <ForeName>Dorota</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Mother and Child Institute, Kasprzaka 17a, 01-211, Warszawa, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Łukaszewicz</LastName>
            <ForeName>Marcin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Biotransformation Department, University of Wroclaw, Plac Uniwersytecki 1, 50-137, Wroclaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Młynarz</LastName>
            <ForeName>Piotr</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Bioorganic Chemistry Group, Faculty of Chemistry, Wroclaw University of Science and Technology, Norwida 4/6, 50-373, Wroclaw, Poland. piotr.mlynarz@pwr.edu.pl.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>World J Microbiol Biotechnol</MedlineTA>
        <NlmUniqueID>9012472</NlmUniqueID>
        <ISSNLinking>0959-3993</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000222" MajorTopicYN="N">Adaptation, Physiological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016680" MajorTopicYN="N">Genome, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076662" MajorTopicYN="N">Host Microbial Interactions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053858" MajorTopicYN="N">Metabolic Networks and Pathways</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055432" MajorTopicYN="Y">Metabolomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011550" MajorTopicYN="N">Pseudomonas aeruginosa</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cystic fibrosis</Keyword>
        <Keyword MajorTopicYN="N">Metabolomic experiment</Keyword>
        <Keyword MajorTopicYN="N">Metabolomics</Keyword>
        <Keyword MajorTopicYN="N">Pseudomonas aeruginosa</Keyword>
        <Keyword MajorTopicYN="N">Strain identification</Keyword>
      </KeywordList>
      <CoiStatement>All authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31701321</ArticleId>
        <ArticleId IdType="pmc">PMC6838043</ArticleId>
        <ArticleId IdType="doi">10.1007/s11274-019-2739-1</ArticleId>
        <ArticleId IdType="pii">10.1007/s11274-019-2739-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bail S, Buchbauer G, Jirovetz L, Denkova Z, Slavchev A, Stoyanova A, Geissler M. Antimicrobial activities of roman chamomile oil from france and its main compounds. J Essent Oil Res. 2009;21(3):283–286. doi: 10.1080/10412905.2009.9700171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10412905.2009.9700171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018;7:1–18. doi: 10.7573/dic.212527.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7573/dic.212527</ArticleId>
            <ArticleId IdType="pmc">PMC5978525</ArticleId>
            <ArticleId IdType="pubmed">29872449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behrends V, Ryall B, Zlosnik JEA, Speert DP, Bundy JG, Williams HD. Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ Microbiol. 2013;15(2):398–408. doi: 10.1111/j.1462-2920.2012.02840.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-2920.2012.02840.x</ArticleId>
            <ArticleId IdType="pubmed">22882524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Behrends V, Williams HD, Bundy JG. Metabolic footprinting: extracellular metabolomic analysis. Methods Mol Biol. 2014;1149:281–292. doi: 10.1007/978-1-4939-0473-0_230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-0473-0_230</ArticleId>
            <ArticleId IdType="pubmed">24818913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bendiak G, Ratjen F. The approach to Pseudomonas aeruginosa in cystic fibrosis. Semin Respir Crit Care Med. 2009;30:587–595. doi: 10.1055/s-0029-1238917.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0029-1238917</ArticleId>
            <ArticleId IdType="pubmed">19760546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breidenstein EBM, de la Fuente-Núñez C, Hancock REW. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19:419–426. doi: 10.1016/j.tim.2011.04.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2011.04.005</ArticleId>
            <ArticleId IdType="pubmed">21664819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen T, Sheng J, Fu Y, Li M, Wang J, Jia AQ. 1H NMR-based global metabolic studies of Pseudomonas aeruginosa upon exposure of the quorum sensing inhibitor resveratrol. J Proteom Res. 2017;16(2):824–830. doi: 10.1021/acs.jproteome.6b00800.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.jproteome.6b00800</ArticleId>
            <ArticleId IdType="pubmed">28094526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chevallereau A, Blasdel BG, De Smet J, Monot M, Zimmermann M, Kogadeeva M, Lavigne R. Next-generation “-omics” approaches reveal a massive alteration of host rna metabolism during bacteriophage infection of Pseudomonas aeruginosa. PLoS Genet. 2016;12(7):e1006134. doi: 10.1371/journal.pgen.1006134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1006134</ArticleId>
            <ArticleId IdType="pmc">PMC4933390</ArticleId>
            <ArticleId IdType="pubmed">27380413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi C, Münch R, Leupold S, Klein J, Siegel I, Thielen B, Jahn D. SYSTOMONAS-an integrated database for systems biology analysis of Pseudomonas. Nucleic Acids Res. 2007;35:533–537. doi: 10.1093/nar/gkl823.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkl823</ArticleId>
            <ArticleId IdType="pmc">PMC1899106</ArticleId>
            <ArticleId IdType="pubmed">17202169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davenport PW, Griffin JL, Welch M. Quorum sensing is accompanied by global metabolic changes in the opportunistic human pathogen Pseudomonas aeruginosa. J Bacteriol. 2015;197(12):2072–2082. doi: 10.1128/JB.02557-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.02557-14</ArticleId>
            <ArticleId IdType="pmc">PMC4438216</ArticleId>
            <ArticleId IdType="pubmed">25868647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Kievit TR. Quorum sensing in Pseudomonas aeruginosa biofilms. Environ Microbiol. 2009;11(2):279–288. doi: 10.1111/j.1462-2920.2008.01792.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-2920.2008.01792.x</ArticleId>
            <ArticleId IdType="pubmed">19196266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Smet J, Zimmermann M, Kogadeeva M, Ceyssens PJ, Vermaelen W, Blasdel B, Bin Jang H, Sauer U, Lavigne R. High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection. ISME J. 2016;10:1823–1835. doi: 10.1038/ismej.2016.3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ismej.2016.3</ArticleId>
            <ArticleId IdType="pmc">PMC5029163</ArticleId>
            <ArticleId IdType="pubmed">26882266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dona AC, Kyriakides M, Scott F, Shephard EA, Varshavi D, Veselkov K, Everett JR. A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments. Comput Struct Biotechnol J. 2016;14:135–153. doi: 10.1016/j.csbj.2016.02.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.csbj.2016.02.005</ArticleId>
            <ArticleId IdType="pmc">PMC4821453</ArticleId>
            <ArticleId IdType="pubmed">27087910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34:91–100. doi: 10.1002/ppul.10127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.10127</ArticleId>
            <ArticleId IdType="pubmed">12112774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiehn O. Metabolomics–the link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1–2):155–171. doi: 10.1023/A:1013713905833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1013713905833</ArticleId>
            <ArticleId IdType="pubmed">11860207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frimmersdorf E, Horatzek S, Pelnikevich A, Wiehlmann L, Schomburg D. How Pseudomonas aeruginosa adapts to various environments: a metabolomic approach. Environ Microbiol. 2010;12(6):1734–1747. doi: 10.1111/j.1462-2920.2010.02253.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-2920.2010.02253.x</ArticleId>
            <ArticleId IdType="pubmed">20553553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gjersing EL, Herberg JL, Horn J, Schaldach CM, Maxwell RS. NMR metabolomics of planktonic and biofilm modes of growth in Pseudomonas aeruginosa. Anal Chem. 2007;79(21):8037–8045. doi: 10.1021/ac070800t.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ac070800t</ArticleId>
            <ArticleId IdType="pubmed">17915964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goo E, An JH, Kang Y, Hwang I. Control of bacterial metabolism by quorum sensing. Trends Microbiol. 2015;23(9):567–576. doi: 10.1016/j.tim.2015.05.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2015.05.007</ArticleId>
            <ArticleId IdType="pubmed">26072043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han ML, Zhu Y, Creek DJ, Lin YW, Anderson D, Shen HH, Li J. Alterations of metabolic and lipid profiles in polymyxin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2018;62(6):e02656. doi: 10.1128/AAC.02656-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.02656-17</ArticleId>
            <ArticleId IdType="pmc">PMC5971563</ArticleId>
            <ArticleId IdType="pubmed">29632014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han ML, Zhu Y, Creek DJ, Lin YW, Gutu AD, Hertzog P, Purcell T, Shen HH, Moskowitz SM, Velkov T, Li J. Comparative metabolomics and transcriptomics reveal multiple pathways associated with polymyxin killing in Pseudomonas aeruginosa. MSystems. 2019;4(1):e00149–e218. doi: 10.1128/mSystems.00149-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mSystems.00149-18</ArticleId>
            <ArticleId IdType="pmc">PMC6325167</ArticleId>
            <ArticleId IdType="pubmed">30637340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W, Brewer LK, Jones JW, Nguyen AT, Marcu A, Wishart DS, Wilks A. PAMDB: A comprehensive Pseudomonas aeruginosa metabolome database. Nucleic Acids Res. 2018;46:575–580. doi: 10.1093/nar/gkx1061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkx1061</ArticleId>
            <ArticleId IdType="pmc">PMC5753269</ArticleId>
            <ArticleId IdType="pubmed">29106626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janek T, Łukaszewicz M, Rezanka T, Krasowska A. Isolation and characterization of two new lipopeptide biosurfactants produced by Pseudomonas fluorescens BD5 isolated from water from the Arctic Archipelago of Svalbard. Bioresour Technol. 2010;101(15):6118–6123. doi: 10.1016/j.bbr.2011.03.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbr.2011.03.031</ArticleId>
            <ArticleId IdType="pubmed">20303744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:353–361. doi: 10.1093/nar/gkw1092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkw1092</ArticleId>
            <ArticleId IdType="pmc">PMC5210567</ArticleId>
            <ArticleId IdType="pubmed">27899662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kesarwani M, Hazan R, He J, Que Y, Apidianakis Y, Lesic B, Xiao G, Dekimpe V, Milot S, Deziel E, Lépine F, Rahme LG. A quorum sensing regulated small volatile molecule reduces acute virulence and promotes chronic infection phenotypes. PLoS Pathog. 2011;7:e1002192. doi: 10.1371/journal.ppat.1002192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1002192</ArticleId>
            <ArticleId IdType="pmc">PMC3150319</ArticleId>
            <ArticleId IdType="pubmed">21829370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Bryant SH. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:1202–1213. doi: 10.1093/nar/gkv951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkv951</ArticleId>
            <ArticleId IdType="pmc">PMC4702940</ArticleId>
            <ArticleId IdType="pubmed">26400175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klockgether J, Miethke N, Kubesch P, Bohn YS, BrockhausenI Cramer N, Tümmler B. Intraclonal diversity of the Pseudomonas aeruginosa cystic fibrosis airway isolates TBCF10839 and TBCF121838: distinct signatures of transcriptome, proteome, metabolome, adherence and pathogenicity despite an almost identical genome sequence. Environ Microbiol. 2013;15(1):191–210. doi: 10.1111/j.1462-2920.2012.02842.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-2920.2012.02842.x</ArticleId>
            <ArticleId IdType="pubmed">22882573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosorok M, Zeng L, West S, Rock M, Splaingard M, Laxova A, Green C, Collins J, Farrell P. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2003;32:277–287. doi: 10.1002/ppul.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.2009</ArticleId>
            <ArticleId IdType="pubmed">11568988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kozlowska J, Rivett DW, Vermeer LS, Carroll MP, Bruce KD, James Mason A, Rogers GB. A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in metabolomic investigation. Metabolomics. 2013;9(6):1262–1273. doi: 10.1007/s11306-013-0538-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11306-013-0538-5</ArticleId>
            <ArticleId IdType="pmc">PMC3868936</ArticleId>
            <ArticleId IdType="pubmed">24367285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawal O, Muhamadali H, Ahmed WM, White IR, Nijsen TME, Goodacre R, Fowler SJ. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS. J Breath Res. 2017;12(2):026002. doi: 10.1088/1752-7163/aa8efc.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1088/1752-7163/aa8efc</ArticleId>
            <ArticleId IdType="pubmed">28947683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawal O, Knobel H, Weda H, Nijsen TME, Goodacre R, Fowler SJ, Zakharkina T. TD/GC–MS analysis of volatile markers emitted from mono- and co-cultures of Enterobacter cloacae and Pseudomonas aeruginosa in artificial sputum. Metabolomics. 2018;14(5):1–11. doi: 10.1007/s11306-018-1357-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11306-018-1357-5</ArticleId>
            <ArticleId IdType="pmc">PMC5920131</ArticleId>
            <ArticleId IdType="pubmed">29725275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J, Zhang L. The hierarchy quorum sensing network in Pseudomonas aeruginosa. Protein Cell. 2015;6(1):26–41. doi: 10.1007/s13238-014-0100-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13238-014-0100-x</ArticleId>
            <ArticleId IdType="pmc">PMC4286720</ArticleId>
            <ArticleId IdType="pubmed">25249263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leon J.  Podstawy mikrobiologii lekarskiej. Warszawa: PZWL; 1979. </Citation>
        </Reference>
        <Reference>
          <Citation>Maniscalco M, Fuschillo S, Paris D, Cutignano A, Sanduzzi A, Motta A. Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases. Adv Clin Chem. 2019;1(88):121–149. doi: 10.1016/bs.acc.2018.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/bs.acc.2018.10.002</ArticleId>
            <ArticleId IdType="pubmed">30612604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montuschi P, Paris D, Melck D, Lucidi V, Ciabattoni G, Raia V, Motta A. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax. 2012;67(3):222–228. doi: 10.1136/thoraxjnl-2011-200072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thoraxjnl-2011-200072</ArticleId>
            <ArticleId IdType="pubmed">22106016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neerincx AH, Geurts BP, Habets MFJ, Booij JA, Van Loon J, Jansen JJ, Kluijtmans LAJ. Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono- and co-cultures based on volatile biomarker combinations. J Breath Res. 2016;10(1):016002. doi: 10.1088/1752-7155/10/1/016002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1088/1752-7155/10/1/016002</ArticleId>
            <ArticleId IdType="pubmed">26824272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen DD, Melnik AV, Koyama N, Lu X, Schorn M, Fang J, Dorrestein PC. Indexing the Pseudomonas specialized metabolome enabled the discovery of poaeamide B and the bananamides. Nature Microbiol. 2017;2(1):16197. doi: 10.1038/nmicrobiol.2016.197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmicrobiol.2016.197</ArticleId>
            <ArticleId IdType="pmc">PMC5538791</ArticleId>
            <ArticleId IdType="pubmed">27798598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001;138:699–704. doi: 10.1067/mpd.2001.112897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mpd.2001.112897</ArticleId>
            <ArticleId IdType="pubmed">11343046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nizio KD, Perrault KA, Troobnikoff AN, Ueland M, Shoma S, Iredell JR, Forbes SL. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study. J Breath Res. 2016;10(2):026008. doi: 10.1088/1752-7155/10/2/026008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1088/1752-7155/10/2/026008</ArticleId>
            <ArticleId IdType="pubmed">27120170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palama TL, Canard I, Rautureau GJP, Mirande C, Chatellier S, Elena-Herrmann B. Identification of bacterial species by untargeted NMR spectroscopy of the exo-metabolome. Analyst. 2016;141:4558–4561. doi: 10.1039/c6an00393a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c6an00393a</ArticleId>
            <ArticleId IdType="pubmed">27349704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parkins MD, Somayaji R, Waters J. Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis. Clin Microbiol Rev. 2018;31(4):1–38. doi: 10.1128/CMR.00019-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00019-18</ArticleId>
            <ArticleId IdType="pmc">PMC6148191</ArticleId>
            <ArticleId IdType="pubmed">30158299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patti GJ, Yanes O, Siuzdak G. Metabolomics: the apogee of the omic triology NIH Public Access. Nat Rev Mol Cell Biol. 2012;13(4):263–269. doi: 10.1038/nrm3314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3314</ArticleId>
            <ArticleId IdType="pmc">PMC3682684</ArticleId>
            <ArticleId IdType="pubmed">22436749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pearson H. Meet the human metabolome. Nature. 2007;446(7131):8. doi: 10.1038/446008a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/446008a</ArticleId>
            <ArticleId IdType="pubmed">17330009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peix A, Ramírez-Bahena MH, Velázquez E. The current status on the taxonomy of Pseudomonas revisited: an update. Infect genet envol. 2018;57:106–116. doi: 10.1016/j.meegid.2017.10.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.meegid.2017.10.026</ArticleId>
            <ArticleId IdType="pubmed">29104095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reading NC, Sperandio V. Quorum sensing: the many languages of bacteria. FEMS Microbiol Lett. 2006;254(1):1–11. doi: 10.1111/j.1574-6968.2005.00001.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6968.2005.00001.x</ArticleId>
            <ArticleId IdType="pubmed">16451172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Righi V, Constantinou C, Kesarwani M, Rahme LG, Tzika AA. Live-cell high resolution magic angle spinning magnetic resonance spectroscopy for in vivo analysis of Pseudomonas aeruginosa metabolomics. Biomed Rep. 2013;1(5):707–712. doi: 10.3892/br.2013.148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/br.2013.148</ArticleId>
            <ArticleId IdType="pmc">PMC3917020</ArticleId>
            <ArticleId IdType="pubmed">24649014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Righi V, Constantinou C, Kesarwani M, Rahme L, Tzika A. Effects of a small, volatile bacterial molecule on Pseudomonas aeruginosa bacteria using whole cell high-resolution magic angle spinning nuclear magnetic resonance spectroscopy and genomics. Int J Mol Med. 2018;42(4):2129–2136. doi: 10.3892/ijmm.2018.3760.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/ijmm.2018.3760</ArticleId>
            <ArticleId IdType="pmc">PMC6108874</ArticleId>
            <ArticleId IdType="pubmed">30015850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robroeks CMHHT, van Berkel JJBN, Dallinga JW, Jöbsis Q, Zimmermann LJI, Hendriks HJE, Dompeling E. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res. 2010;68(1):75–80. doi: 10.1203/PDR.0b013e3181df4ea0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1203/PDR.0b013e3181df4ea0</ArticleId>
            <ArticleId IdType="pubmed">20351658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romero P, Karp P. PseudoCyc, a pathway-genome database for Pseudomonas aeruginosa. J Mol Microbiol Biotechnol. 2003;5(4):230–239. doi: 10.1159/000071075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000071075</ArticleId>
            <ArticleId IdType="pubmed">12867747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt KD, Tümmler B, Römling U. Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J Bacteriol. 1996;178:85–93. doi: 10.1128/jb.178.1.85-93.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.178.1.85-93.1996</ArticleId>
            <ArticleId IdType="pmc">PMC177624</ArticleId>
            <ArticleId IdType="pubmed">8550447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thippakorn C, Isarankura-Na-Ayudhya C, Pannengpetch S, Isarankura-Na-Ayudhya P, Schaduangrat N, Nantasenamat C, Virapong P. Oxidative responses and defense mechanism of hyperpigmented P. aeruginosa as characterized by proteomics and metabolomics. EXCLI J. 2018;17:544. doi: 10.17179/excli2018-1238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17179/excli2018-1238</ArticleId>
            <ArticleId IdType="pmc">PMC6046631</ArticleId>
            <ArticleId IdType="pubmed">30034318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winsor GL, Griffiths EJ, Lo R, Dhillon BK, ShayJA Brinkman FSL. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res. 2016;44:646–653. doi: 10.1093/nar/gkv1227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkv1227</ArticleId>
            <ArticleId IdType="pmc">PMC4702867</ArticleId>
            <ArticleId IdType="pubmed">26578582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winstanley C, O’Brien S, Brockhurst MA. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 2016;24(5):327–337. doi: 10.1016/j.tim.2016.01.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2016.01.008</ArticleId>
            <ArticleId IdType="pmc">PMC4854172</ArticleId>
            <ArticleId IdType="pubmed">26946977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Scalbert A. HMDB 3.0-The human metabolome database in 2013. Nucleic Acids Res. 2013;41:801–807. doi: 10.1093/nar/gks1065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gks1065</ArticleId>
            <ArticleId IdType="pmc">PMC3531200</ArticleId>
            <ArticleId IdType="pubmed">23161693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Worley B, Powers R. Multivariate analysis in metabolomics Curr Metabol. 2013;1(1):92–107. doi: 10.2174/2213235X11301010092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/2213235X11301010092</ArticleId>
            <ArticleId IdType="pmc">PMC4465187</ArticleId>
            <ArticleId IdType="pubmed">26078916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu YJ, Wang C, Ho WE, Ong CN. Recent developments and applications of metabolomics in microbiological investigations. Trends Anal Chem. 2014;56:37–48. doi: 10.1016/j.trac.2013.12.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trac.2013.12.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao X, Shen M, Jiang X, Shen W, Zhong Q, Yang Y, Le S. Transcriptomic and metabolomics profiling of phage–host interactions between PHAGE PaP1 and Pseudomonas aeruginosa. Front Microbiol. 2017;8:1–10. doi: 10.3389/fmicb.2017.00548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2017.00548</ArticleId>
            <ArticleId IdType="pmc">PMC5377924</ArticleId>
            <ArticleId IdType="pubmed">28421049</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
